The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Exelixis, Inc(NASDAQ:EXEL) 
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who receiv...
Website: http://www.exelixis.com
Founded: 1994
Full Time Employees: 617
Sector: Healthcare
Industry: Biotechnology
Exelixis Days Payable Outstanding ttm (DPO)
Exelixis Days Receivable Outstanding ttm (DSO)
Exelixis Days Inventory Outstanding ttm (DIO)
Exelixis Op Cashflow Per Share ttm
Exelixis Free Cashflow Per Share ttm
Exelixis Cash Per Share ttm
Exelixis P/S ratio ttm
Exelixis (GAAP) P/E ratio ttm
Exelixis P/B ratio ttm
No extra charts and metrics for this ticker.